HIMS & HERS HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.5 USD | +1.87% |
|
+5.04% | +40.45% |
| 04-26 | Seaport Global Starts Hims & Hers Health With Buy Rating | MT |
| 04-16 | Jefferies Downgrades Hims & Hers Health to Hold From Buy, Cuts Price Target to $15 From $17 | MT |
Chart calendar Hims & Hers Health, Inc.
e191a31dd5c9b68f5ef89aeb26b9c8.nRb9cyDR-8zqE6-rewZyuujxRwkGI9eZH-K0-BrwPUo.6iaEF2-5so3fI-X_TWMq7aqECD9NFJz2cb3WsEWRCg_lQJUBSOO9molh2A~fd348ddb799f16984558d699f94ac791
Upcoming events on Hims & Hers Health, Inc.
Past events on Hims & Hers Health, Inc.
| 14/03/2024 19:45 | CG eCommerce Sustainable Advantage Forum |
| 05/03/2024 | Morgan Stanley Technology, Media & Telecom Conference |
| 26/02/2024 22:00 | Q4 2023 Earnings Call |
| 26/02/2024 21:05 | Q4 2023 Earnings Release |
| 06/11/2023 22:00 | Q3 2023 Earnings Call |
| 06/11/2023 21:05 | Q3 2023 Earnings Release |
| 07/08/2023 22:00 | Q2 2023 Earnings Call |
| 07/08/2023 21:15 | Q2 2023 Earnings Release |
| 31/05/2023 | Annual General Meeting |
| 10/05/2023 23:40 | Bank of America Healthcare Conference |
| 08/05/2023 22:00 | Q1 2023 Earnings Call |
| 08/05/2023 21:15 | Q1 2023 Earnings Release |
| 08/03/2023 21:30 | KeyBanc Capital Markets Emerging Technology Summit |
| 07/03/2023 22:30 | JMP Securities Technology Conference |
| 02/03/2023 15:15 | Citi Healthcare Services Medtech Tools & HCIT Conference |
| 27/02/2023 22:00 | Q4 2022 Earnings Call |
| 27/02/2023 21:15 | Q4 2022 Earnings Release |
| 07/11/2022 22:00 | Q3 2022 Earnings Call |
| 07/11/2022 21:15 | Q3 2022 Earnings Release |
| 08/08/2022 22:00 | Interim 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 82,6 | 149 144 3.1% | 272 264 2.91% | 527 521 1.15% | 872 872 0.01% | 1 192 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -8,11 -15,3 47.07% | -30,1 -37,0 18.78% | -15,8 -18,7 15.59% | 49,5 44,2 11.91% | 114 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -15,1 -21,7 30.16% | -115 -117 2.03% | -68,7 -69,0 0.4% | -29,5 -33,3 11.48% | 22,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -18,0 -40,2 55.25% | -111 -105 -5.5% | -65,7 -66,0 0.44% | -21,6 -26,5 18.64% | 31,3 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -18,1 -31,3 42.16% | -108 -83,0 -29.78% | -65,7 -68,0 3.36% | -23,5 -30,1 21.88% | 25,1 |
|
EPS USD | Released Forecast Spread | -0,94 | -0,23 -0,40 42.5% | -0,58 -0,53 -9.43% | -0,32 -0,33 3.01% | -0,11 -0,14 18.83% | 0,08 |
| Announcement Date | 23/10/20 | 18/03/21 | 22/02/22 | 27/02/23 | 26/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 84,7 76,8 10.29% | 101 91,0 11.34% | 114 104 9.31% | 145 130 11.13% | 167 161 3.74% | 191 179 6.53% | 208 205 1.44% | 227 220 3.01% | 247 246 0.06% | 269 | 286 | 305 | 322 | 335 |
|
EBITDA Million USD | Released Forecast Spread | -7,06 -14,4 51.06% | -6,06 -10,2 40.85% | -7,54 -8,15 7.52% | -6,10 -9,22 33.86% | 3,92 1,06 270.46% | 6,06 4,23 43.11% | 10,6 6,27 69.51% | 12,3 11,8 3.81% | 20,6 15,5 32.51% | 24,0 | 25,6 | 27,8 | 31,8 | 36,8 |
|
EBIT Million USD | Released Forecast Spread | -21,6 -26,1 17.45% | -16,9 -22,9 26.03% | -20,2 -21,3 5.12% | -20,0 -20,5 2.72% | -11,6 -12,3 5.44% | -11,3 -11,0 -2.12% | -9,24 -11,0 16.37% | -8,55 -7,61 -12.4% | -0,40 -4,60 91.31% | 3,96 | 3,76 | 4,53 | 9,48 | 14,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -31,2 -33,3 6.24% | -16,2 -17,4 6.89% | -19,7 -20,0 1.63% | -18,9 -19,9 5.25% | -11,0 -11,6 5.11% | -9,68 -10,6 9.05% | -7,17 -9,40 23.75% | -6,92 -6,07 -13.99% | 2,20 -3,17 169.32% | 6,05 | 5,89 | 6,64 | 11,8 | 15,5 |
|
Net income Million USD | Released Forecast Spread | -31,2 -27,7 -12.66% | -16,3 -19,2 15.53% | -19,7 -20,4 3.66% | -18,8 -20,8 9.25% | -10,9 -13,4 18.42% | -10,1 -12,5 19.59% | -7,16 -11,7 39.04% | -7,57 -6,58 -14.99% | 1,25 -3,83 132.54% | 5,05 | 4,91 | 5,61 | 9,94 | 11,2 |
|
EPS USD | Released Forecast Spread | -0,15 -0,10 -57.89% | -0,08 -0,08 2.31% | -0,10 -0,09 -7.74% | -0,09 -0,10 7.34% | -0,05 -0,06 13.55% | -0,05 -0,05 -3.69% | -0,03 -0,04 31.9% | -0,04 -0,03 -19.23% | 0,01 -0,02 156.5% | 0,01 | 0,01 | 0,02 | 0,03 | 0,05 |
| Announcement Date | 22/02/22 | 09/05/22 | 08/08/22 | 07/11/22 | 27/02/23 | 08/05/23 | 07/08/23 | 06/11/23 | 26/02/24 | - | - | - | - | - |
More events
Past sector events for Hims & Hers Health, Inc.
| 25/04/2024 21:05 | TELADOC HEALTH, INC.: Q1 2024 Earnings Release |
| 26/02/2024 21:05 | HIMS & HERS HEALTH, INC.: Q4 2023 Earnings Release |
| 22/02/2024 13:00 | TALKSPACE, INC.: Q4 2023 Earnings Release |
| 20/02/2024 21:05 | TELADOC HEALTH, INC.: Q4 2023 Earnings Release |
| 06/11/2023 21:05 | HIMS & HERS HEALTH, INC.: Q3 2023 Earnings Release |
| 24/10/2023 21:05 | TELADOC HEALTH, INC.: Q3 2023 Earnings Release |
| 07/08/2023 21:15 | HIMS & HERS HEALTH, INC.: Q2 2023 Earnings Release |
| 25/07/2023 21:05 | TELADOC HEALTH, INC.: Q2 2023 Earnings Release |
| 08/05/2023 21:15 | HIMS & HERS HEALTH, INC.: Q1 2023 Earnings Release |
| 26/04/2023 21:05 | TELADOC HEALTH, INC.: Q1 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- HIMS Stock
- Calendar Hims & Hers Health, Inc.
